FDA Unveils New Fee Proposal For Drug Reviews
The U.S. Food and Drug Administration published a draft proposal Thursday promising it would review new drugs more quickly under a reauthorized Prescription Drug User Fee Act in exchange for a...To view the full article, register now.
Already a subscriber? Click here to view full article